Phreesia (NYSE:PHR) Shares Gap Up – What’s Next?

Phreesia, Inc. (NYSE:PHR) shares gapped up before the market opened on Friday . The stock had previously closed at $11.42, but opened at $12.60. Phreesia shares last traded at $12.8730, with a volume of 230,378 shares changing hands.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Canaccord Genuity Group reduced their price objective on shares of Phreesia from $22.00 to $16.00 and set a “buy” rating on the stock in a research report on Thursday, May 28th. Piper Sandler cut shares of Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 target price for the company. in a research note on Thursday, May 28th. Barclays reiterated an “equal weight” rating and issued a $10.00 price target (down from $24.00) on shares of Phreesia in a report on Thursday, May 14th. DA Davidson reissued a “buy” rating and set a $14.00 price objective on shares of Phreesia in a report on Thursday, May 28th. Finally, Weiss Ratings upgraded Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a research report on Monday, July 20th. Nine investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $16.65.

Phreesia Stock Performance

The business’s fifty day moving average is $10.23 and its two-hundred day moving average is $10.74. The stock has a market capitalization of $774.23 million, a PE ratio of 83.53 and a beta of 0.85. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.41.

Phreesia (NYSE:PHR) last released its earnings results on Wednesday, May 27th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.03. The firm had revenue of $130.94 million for the quarter, compared to the consensus estimate of $130.08 million. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.07) EPS. As a group, research analysts anticipate that Phreesia, Inc. will post 0.39 EPS for the current fiscal year.

Institutional Investors Weigh In On Phreesia

Several institutional investors have recently made changes to their positions in PHR. Raymond James Financial Inc. grew its stake in shares of Phreesia by 2.7% during the second quarter. Raymond James Financial Inc. now owns 14,049 shares of the company’s stock worth $400,000 after acquiring an additional 375 shares during the last quarter. Alliancebernstein L.P. increased its holdings in shares of Phreesia by 1.3% during the third quarter. Alliancebernstein L.P. now owns 62,712 shares of the company’s stock valued at $1,475,000 after acquiring an additional 812 shares in the last quarter. Van ECK Associates Corp raised its holdings in shares of Phreesia by 78.7% in the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after buying an additional 1,102 shares during the last quarter. Deutsche Bank AG grew its holdings in shares of Phreesia by 2.4% during the fourth quarter. Deutsche Bank AG now owns 66,288 shares of the company’s stock valued at $1,122,000 after buying an additional 1,540 shares during the last quarter. Finally, KBC Group NV increased its position in shares of Phreesia by 83.4% in the 4th quarter. KBC Group NV now owns 3,449 shares of the company’s stock valued at $58,000 after acquiring an additional 1,568 shares during the period. Institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.